Benefits of topiramate treatment in a dual-diagnosis patient

Psychosomatics

Volumn 50, Issue 4, 2009, Pages 426-427

  Miller, Jason ^a   Roache, John ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; TOPIRAMATE;

ADOLESCENT; ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; AUDITORY HALLUCINATION; CASE REPORT; COMORBIDITY; DIABETES MELLITUS; DRUG DOSE TITRATION; DUAL DIAGNOSIS; FRONTAL CORTEX; HUMAN; LETTER; MALE; OBESITY; PARANOIA; PATIENT COUNSELING; PSYCHOSIS; SIDE EFFECT; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; BRAIN INJURIES; CLOZAPINE; FRUCTOSE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; PSYCHOTIC DISORDERS;

EID: 69249153013     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.50.4.426     Document Type: Letter

References (6)

1. Bartels SJ, Teague GB, Drake RE, et al: Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis 1993; 181:227-232 (Pubitemid 23233328)
2. Johnson BA, Rosenthal N, Capece JA, et al: Topiramate for treating alcohol dependence: a randomized, controlled trial. JAMA 2007; 298:1641-1651 (Pubitemid 47606653)
3. Bray GA, Hollander P, Klein S, et al: A 6-month, randomized, placebo controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003; 11:722-733 (Pubitemid 41151598)
4. Wahlbeck K, Cheine MV, Essali A: Clozapine versus typical neuroleptic medications for schizophrenia. Cochrane Database of Systematic Reviews, 1999. Issue 4, Article No: CD000059. DOI: 10.1002/14651858.CD000059
5. Cleary M, Hunt G, Matheson S, et al: Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Systematic Reviews, 2008. Jan 23:(1):CD001088
6. Carrelli RM: The nucleus accumbens and reward: neurophysiological investigations in behaving animals. Behav Cogn Neurosci Rev 2002; 1:281-296